These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10535384)

  • 1. Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus.
    Clemens A; Klevesath MS; Hofmann M; Raulf F; Henkels M; Amiral J; Seibel MJ; Zimmermann J; Ziegler R; Wahl P; Nawroth PP
    Metabolism; 1999 Oct; 48(10):1236-40. PubMed ID: 10535384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Schmidt AM; Fiehn W; Ziegler R; Wahl P; Nawroth PP
    Diabetes Care; 1998 May; 21(5):841-8. PubMed ID: 9589252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study.
    Morcos M; Borcea V; Isermann B; Gehrke S; Ehret T; Henkels M; Schiekofer S; Hofmann M; Amiral J; Tritschler H; Ziegler R; Wahl P; Nawroth PP
    Diabetes Res Clin Pract; 2001 Jun; 52(3):175-83. PubMed ID: 11323087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction.
    Schalkwijk CG; Ter Wee PM; Stehouwer CD
    Ann N Y Acad Sci; 2005 Jun; 1043():662-70. PubMed ID: 16037290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus.
    Borcea V; Morcos M; Isermann B; Henkels M; Ziegler S; Zumbach M; Amiral J; Längst KD; Seiz W; Ziegler R; Wahl P; Nawroth PP
    Vasa; 1999 Aug; 28(3):172-80. PubMed ID: 10483322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
    Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
    Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Fiehn W; Ziegler R; Wahl P; Nawroth PP
    Diabetes Care; 1997 Dec; 20(12):1880-6. PubMed ID: 9405911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus.
    Smulders RA; Stehouwer CD; Schalkwijk CG; Donker AJ; van Hinsbergh VW; TeKoppele JM
    Thromb Haemost; 1998 Jul; 80(1):52-7. PubMed ID: 9684785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of diabetic retinopathy during improved metabolic control may be treated with reduced insulin dosage and/or somatostatin analogue administration -- a case report.
    Chantelau E; Frystyk J
    Growth Horm IGF Res; 2005 Apr; 15(2):130-5. PubMed ID: 15809016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
    Ebeling P; Koivisto VA
    Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly.
    Cozzi R; Dallabonzana D; Attanasio R; Barausse M; Oppizzi G
    Eur J Endocrinol; 1999 Sep; 141(3):267-71. PubMed ID: 10474124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.
    Yu Y; Suo L; Yu H; Wang C; Tang H
    Diabetes Res Clin Pract; 2004 Aug; 65(2):95-104. PubMed ID: 15223221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice.
    Grønbaek H; Nielsen B; Schrijvers B; Vogel I; Rasch R; Flyvbjerg A
    J Endocrinol; 2002 Mar; 172(3):637-43. PubMed ID: 11874712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
    Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A
    Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
    Levitt NS; Adams G; Salmon J; Marks IN; Musson G; Swanepoel C; Levy M; Byrne MJ
    Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with diabetic microangiopathy: a study of 157 type I (insulin-dependent) diabetic patients.
    Billault BM; Passa PL
    J Diabet Complications; 1991; 5(4):238-43. PubMed ID: 1779019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS).
    Reichard P
    Diabetes Res Clin Pract; 1992 May; 16(2):151-6. PubMed ID: 1600854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus.
    Shimano H; Takahashi K; Kawakami M; Gotoda T; Harada K; Shimada M; Yazaki Y; Yamada N
    Clin Chim Acta; 1994 Mar; 225(2):89-96. PubMed ID: 8088010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.